Compare AVTX & HIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVTX | HIPO |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | 33 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.1M | 850.8M |
| IPO Year | 2015 | 2020 |
| Metric | AVTX | HIPO |
|---|---|---|
| Price | $12.14 | $34.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $44.08 | $40.88 |
| AVG Volume (30 Days) | ★ 959.1K | 162.2K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 72.07 | ★ 235.37 |
| EPS | N/A | ★ 0.65 |
| Revenue | $27,813,137.00 | ★ $468,600,000.00 |
| Revenue This Year | N/A | $24.25 |
| Revenue Next Year | N/A | $34.47 |
| P/E Ratio | ★ N/A | $52.78 |
| Revenue Growth | ★ 2312.27 | 25.93 |
| 52 Week Low | $12.51 | $24.08 |
| 52 Week High | $24.27 | $38.73 |
| Indicator | AVTX | HIPO |
|---|---|---|
| Relative Strength Index (RSI) | 22.50 | 65.10 |
| Support Level | N/A | $29.47 |
| Resistance Level | $20.54 | $34.88 |
| Average True Range (ATR) | 0.84 | 0.94 |
| MACD | -0.17 | 0.37 |
| Stochastic Oscillator | 1.24 | 85.45 |
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.